Global Business Leader | Global Innovation, Coming for Patients, Dialogue with Olivier LAUREAU, President of Schweria Group

Global Business Leader | Global Innovation, for Patients, Dialogue with Olivier LAUREAU, President of Schweria Group. As an international pharmaceutical group managed by a non-profit foundation, Schweria has focused its strategic goals on the fields of refractory tumors and neuroscience in the past few years. At the same time, regarding China as a pivotal strategic market not only concerns Schwyz's own strategic transformation, but also drives China to accelerate the introduction of innovative drugs and fill clinical gaps. Today's Global Business Leaders program is honored to invite Mr. Olivier LAUREAU, President of Schweria Group and CEO of Schweria International Research Foundation, to share with us Schweria's strategic innovations and the role of the Chinese market in Schweria's global landscape.